NCT06109779 2026-03-04
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
AstraZeneca
Phase 3 Active not recruiting
AstraZeneca
RedHill Biopharma Limited
Concordia Laboratories Inc.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.